Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease

Abroad (travel likely)RecruitingPHASE2

Conditions

Dementia · Alzheimers Disease · Mild Cognitive Impairment Due to Alzheimer's Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Gad Marshall, MD) · foralumab@mgb.org · 617-525-6754

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies

Alzheimer's Disease · Dementia

Abroad (travel likely)Recruiting

Phoenix, United States

Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside

Alzheimer Disease · Dementia Alzheimers · Dementia

Abroad (travel likely)Recruiting

Belmont, United States

Hainan Community Cognition Cohort

Cognitive Impairment · Dementia · Age Problems

Abroad (travel likely)Recruiting

Haikou, China

Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis

Lewy Body Dementia Psychosis

Abroad (travel likely)RecruitingPHASE2

Irvine, United States · Washington D.C., United States